Clinical and radiologic features of the first cured Coronavirus disease 2019 (COVID-19) patient in Guangzhou City, China
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bagiella E, Bhatt DL, Gaudino M. The consequences of the COVID-19 pandemic on non-COVID-19 clinical trials. J Am Coll Cardiol. 2020. https://doi.org/10.1016/j.jacc.2020.05.041.
Coronavirus disease (COVID-19) Situation Report—132, Data as received by WHO from national authorities by 10:00 CEST, 31 May 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200531-covid-19-sitrep-132.pdf?sfvrsn=d9c2eaef_2. Accessed 1 June 2020.
Ooi GC, Khong PL, Müller NL, Yiu WC, Zhou LJ, Ho JC, et al. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology. 2004;230(3):836–44. https://doi.org/10.1148/radiol.2303030853.
China National Health Commission, Diagnosis and treatment of pneumonitis caused by new coronavirus. (4th edition, in Chinese) https://www.nhc.gov.cn/yzygj/s7653p/202001/4294563ed35b43209b31739bd0785e67.shtml. Accessed 27 Jan 2020.
China National Health Commission, Diagnosis and treatment of pneumonitis caused by new coronavirus. (5th edition, in Chinese) https://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml. Accessed 5 Feb 2020.
China National Health Commission, Diagnosis and treatment of pneumonitis caused by new coronavirus. (6th edition, in Chinese). https://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. Accessed 19 Feb 2020.
China National Health Commission, Diagnosis and treatment of pneumonitis caused by new coronavirus. (7th edition, in Chinese) https://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml. Accessed 3 Mar 2020.
Liu M, Gao Y, Yuan Y, Yang K, Shi S, Zhang J, et al. Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis. Pharmacol Res. 2020. https://doi.org/10.1016/j.phrs.2020.104896.
Hu K, Guan WJ, Bi Y, Zhang W, Li L, Zhang B, et al. Efficacy and safety of lianhuaqingwen capsules, a repurposed Chinese herb, in patients with Coronavirus Disease 2019: a multicenter, prospective, randomized controlled trial. Phytomed Int J Phytother Phytopharmacol. 2020. https://doi.org/10.1016/j.phymed.2020.153242.
Xu P, Huang J, Fan Z, Huang W, Qi M, Lin X, et al. Arbidol/IFN-α2b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study. Microbes Infect. 2020. https://doi.org/10.1016/j.micinf.2020.05.012.
Arbidol VN. A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein. Int J Antimicrob Agents. 2020. https://doi.org/10.1016/j.ijantimicag.2020.105998.
Deng L, Li C, Zeng Q, Liu X, Li X, Zhang H, et al. Arbidol combined with LPV/r versus LPV/r alone against corona virus disease 2019: a retrospective cohort study. J Infect. 2020. https://doi.org/10.1016/j.jinf.2020.03.002.